Abstract
Surgical treatment of head and neck cancer, in certain cases, inflicts large tissue defects. Some of these defects are associated with devastating functional deficits and disfiguring deformities. In addition, radiation therapy, whenever necessary, often leads to wound breakdown, dehiscence and fistula formation, due to healing mechanism impairment. The advent, development, and nowadays routine use of microsurgical techniques has revolutionized the reconstructive approach in this patient population and changed the outcomes dramatically. Free flap use has both ensured the best possible function and aesthetics and become the "gold standard" in complex head and neck reconstruction. Defects of the head and neck can be anatomically grouped into the following categories: a. Skull base, b. Midface, c. Tongue, d. Oral cavity, e. Mandible and f. Hypopharynx, larynx and cervical esophagus. Certain reconstructive goals should be met for each of these categories. Objectives of this article are threefold. First, to report the reconstructive goals in patients with head and neck cancer, second, to outline the indications of free flap use for each category of head and neck defects due to cancer therapy, and third to review in detail the free flap reconstructive options with respect to functional and aesthetic restoration for each kind of defect, according to the recent international literature.
Keywords: Head and neck cancer, tissue defect, microsurgical reconstruction, free flap
Current Cancer Therapy Reviews
Title: Free Flap Head and Neck Reconstruction After Cancer Therapy: Current State of the Art
Volume: 2 Issue: 1
Author(s): Efstathios G. Lykoudis, Marios G. Salmas and Dimitrios A. Assimakopoulos
Affiliation:
Keywords: Head and neck cancer, tissue defect, microsurgical reconstruction, free flap
Abstract: Surgical treatment of head and neck cancer, in certain cases, inflicts large tissue defects. Some of these defects are associated with devastating functional deficits and disfiguring deformities. In addition, radiation therapy, whenever necessary, often leads to wound breakdown, dehiscence and fistula formation, due to healing mechanism impairment. The advent, development, and nowadays routine use of microsurgical techniques has revolutionized the reconstructive approach in this patient population and changed the outcomes dramatically. Free flap use has both ensured the best possible function and aesthetics and become the "gold standard" in complex head and neck reconstruction. Defects of the head and neck can be anatomically grouped into the following categories: a. Skull base, b. Midface, c. Tongue, d. Oral cavity, e. Mandible and f. Hypopharynx, larynx and cervical esophagus. Certain reconstructive goals should be met for each of these categories. Objectives of this article are threefold. First, to report the reconstructive goals in patients with head and neck cancer, second, to outline the indications of free flap use for each category of head and neck defects due to cancer therapy, and third to review in detail the free flap reconstructive options with respect to functional and aesthetic restoration for each kind of defect, according to the recent international literature.
Export Options
About this article
Cite this article as:
Lykoudis G. Efstathios, Salmas G. Marios and Assimakopoulos A. Dimitrios, Free Flap Head and Neck Reconstruction After Cancer Therapy: Current State of the Art, Current Cancer Therapy Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339406775471768
DOI https://dx.doi.org/10.2174/157339406775471768 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transferrin Coupled Liposomes for Enhanced Brain Delivery of Doxorubicin
Vascular Disease Prevention (Discontinued) The Novel RARβ Isoform (β 5) is a Potential Target of Retinoids in Breast Cancer
Current Cancer Drug Targets Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Current Drug Targets Unlocking the Molecular Mechanisms of DNA Repair and Platinum Drug Resistance in Cancer Chemotherapy
Current Drug Therapy Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Current Medicinal Chemistry Osteopontin: An Effector and an Effect of Tumor Metastasis
Current Molecular Medicine ALDH2---The Genetic Polymorphism and Enzymatic Activity Regulation: Their Epidemiologic and Clinical Implications
Current Drug Targets Mesenchymal Stem Cells Regulate Cytoskeletal Dynamics and Promote Cancer Cell Invasion Through Low Dose Nitric Oxide
Current Molecular Medicine A Review on Extraction, Synthesis and Anticancer Activity of Betulinic Acid
Current Bioactive Compounds Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?
Current Medicinal Chemistry Carrier Deformability in Drug Delivery
Current Pharmaceutical Design Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
Current Cancer Drug Targets Integrating LASSO Feature Selection and Soft Voting Classifier to Identify Origins of Replication Sites
Current Genomics Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update
Current Topics in Medicinal Chemistry An Insight into the Dermatological Applications of Neem: A Review on Traditional and Modern Aspect
Recent Advances in Anti-Infective Drug Discovery Advances in Clinical Study of Curcumin
Current Pharmaceutical Design Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets Chemoresistance of Cancer Cells: Oncogenic Mutation of the p53 Tumor Suppressor Gene
Current Signal Transduction Therapy Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme
Current Molecular Pharmacology Antitumor Activities of Interleukin-27 on Melanoma
Endocrine, Metabolic & Immune Disorders - Drug Targets